Skip to main content
logo
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.120
+0.080 (3.92%)
Nov 4, 2026, 3:18 PM EST - Market open

Altimmune Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
412394513604808363
Market Cap Growth
15.38%-23.16%-15.16%-25.23%122.62%-12.91%
Enterprise Value
122199375464608165
Last Close Price
2.043.617.2111.2516.459.16

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-3.913.913.913.913.91
PS Ratio
13082.889610.9725640.431418.90-11888.9082.35
PB Ratio
0.841.754.153.114.361.82
P/TBV Ratio
0.861.754.153.114.681.95

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
3719.634858.0118760.081090.28-37.39

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.080.160.010.000.010.01
Net Debt / Equity Ratio
-0.61-1.06-1.05-1.02-0.99-0.95
Net Debt / EBITDA Ratio
2.942.521.262.372.112.24
Net Debt / FCF Ratio
3.793.521.632.602.932.09
Asset Turnover
0000.00-0.02
Quick Ratio
26.3718.3512.9016.6910.9910.73
Current Ratio
26.7818.5513.1117.2611.3111.17
Return on Equity (ROE)
-28.88%-50.57%-59.86%-46.63%-44.07%-45.69%
Return on Assets (ROA)
-17.20%-28.17%-36.85%-25.00%-25.73%-22.86%
Return on Capital Employed (ROCE)
-19.20%-35.70%-80.10%-42.10%-46.20%-42.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-34.24%-22.36%-18.54%-14.63%-10.48%-26.74%
FCF Yield
-18.88%-17.14%-15.57%-12.55%-7.76%-24.88%
Buyback Yield / Dilution
-68.90%-24.08%-33.35%-13.47%-13.67%-61.03%
SEC Filings: 10-K · 10-Q